Suppr超能文献

内侧与外侧半月板同种异体移植的中期和长期结果:一项荟萃分析。

Midterm and Long-term Results of Medial Versus Lateral Meniscal Allograft Transplantation: A Meta-analysis.

机构信息

Department of Orthopedic Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Republic of Korea.

Department of Orthopedic Surgery, Ilsanpaik Hospital, Inje University College of Medicine, Goyangsi, Republic of Korea.

出版信息

Am J Sports Med. 2018 Apr;46(5):1243-1250. doi: 10.1177/0363546517709777. Epub 2017 Jun 13.

Abstract

BACKGROUND

It is unclear whether lateral meniscal allograft transplantation (MAT) procedures lead to better clinical outcomes than medial MAT.

HYPOTHESIS

The survival rates are similar between medial and lateral MAT, but the clinical outcomes of lateral MAT are better than those of medial MAT at final follow-up.

STUDY DESIGN

Meta-analysis.

METHODS

In this meta-analysis, we reviewed studies that assessed survival rates in patients who underwent medial or lateral MAT with more than 5 years of follow-up and that used assessments such as pain and Lysholm scores to compare postoperative scores on knee outcome scales. The survival time was considered as the time to conversion to knee arthroplasty and/or subtotal resection of the allograft.

RESULTS

A total of 9 studies (including 287 knees undergoing surgery using medial MAT and 407 with lateral MAT) met the inclusion criteria and were analyzed in detail. The proportion of knees in which midterm (5-10 years) survival rates (medial, 97/113; lateral, 108/121; odds ratio [OR] 0.71; 95% CI, 0.31-1.64; P = .42) and long-term (>10 years) survival rates (medial, 303/576; lateral, 456/805; OR 0.78; 95% CI, 0.52-1.17; P = .22) were evaluated did not differ significantly between medial and lateral MAT. In addition, both groups had substantial proportions of knees exhibiting midterm survivorship (85.8% for medial MAT and 89.2% for lateral MAT) but much lower proportions of knees exhibiting long-term survivorship (52.6% for medial MAT and 56.6% for lateral MAT). In contrast, overall pain score (medial, 65.6 points; lateral, 71.3 points; 95% CI, -3.95 to -0.87; P = .002) and Lysholm score (medial, 67.5 points; lateral, 72.0 points; 95% CI, -10.17 to -3.94; P < .00001) were significantly higher for lateral MAT compared with medial MAT.

CONCLUSION

Meta-analysis indicated that 85.8% of medial and 89.2% of lateral meniscal allograft transplants survive at midterm (5-10 years) while 52.6% of medial and 56.6% of lateral meniscal allograft transplants survive long term (>10 years). Patients undergoing lateral meniscal allograft transplantation demonstrated greater pain relief and functional improvement than patients undergoing medial meniscal allograft transplantations.

摘要

背景

目前尚不清楚外侧半月板同种异体移植(MAT)手术是否比内侧 MAT 手术能带来更好的临床结果。

假设

内侧和外侧 MAT 的存活率相似,但外侧 MAT 的临床结果优于内侧 MAT,随访终末时更优。

研究设计

荟萃分析。

方法

在这项荟萃分析中,我们回顾了评估内侧和外侧 MAT 患者存活率的研究,这些研究的随访时间超过 5 年,并使用疼痛和 Lysholm 评分等评估方法比较了膝关节结果量表上的术后评分。生存时间被认为是转换为膝关节置换术和/或同种异体移植物次全切除的时间。

结果

共有 9 项研究(包括内侧 MAT 手术的 287 个膝关节和外侧 MAT 手术的 407 个膝关节)符合纳入标准并进行了详细分析。中期(5-10 年)存活率(内侧,97/113;外侧,108/121;优势比[OR]0.71;95%CI,0.31-1.64;P=0.42)和长期(>10 年)存活率(内侧,303/576;外侧,456/805;OR0.78;95%CI,0.52-1.17;P=0.22)在接受内侧和外侧 MAT 手术的患者之间差异无统计学意义。此外,两组均有相当比例的膝关节具有中期存活率(内侧 MAT 为 85.8%,外侧 MAT 为 89.2%),但具有长期存活率的膝关节比例要低得多(内侧 MAT 为 52.6%,外侧 MAT 为 56.6%)。相比之下,外侧 MAT 的总体疼痛评分(内侧,65.6 分;外侧,71.3 分;95%CI,-3.95 至-0.87;P=0.002)和 Lysholm 评分(内侧,67.5 分;外侧,72.0 分;95%CI,-10.17 至-3.94;P<.00001)明显高于内侧 MAT。

结论

荟萃分析表明,85.8%的内侧和 89.2%的外侧半月板同种异体移植物在中期(5-10 年)存活,而 52.6%的内侧和 56.6%的外侧半月板同种异体移植物在长期(>10 年)存活。接受外侧半月板同种异体移植的患者比接受内侧半月板同种异体移植的患者疼痛缓解和功能改善更明显。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验